Perrigo

Perrigo, established in 1887, is a prominent global healthcare supplier specializing in the manufacturing of private label over-the-counter pharmaceuticals. The company maintains a robust, diversified portfolio that includes nutritional supplements, generic medications, and personal hygiene products. Operating as a key player in the pharmaceutical sector, Perrigo focuses on delivering accessible, high-quality wellness solutions to consumers worldwide. Their commitment to health-care excellence is reflected in their long-standing history of providing reliable, non-prescription alternatives that meet rigorous safety and quality standards for mass-market retail.

With a workforce spanning 5,000-10,000 employees, Perrigo manages 15 global locations to support its extensive, international supply chain. The company’s product suite encompasses diverse categories such as dermatological treatments, infant formula, and nicotine replacement therapies. By leveraging a sophisticated, scalable business model, Perrigo ensures the efficient distribution of high-quality, FDA-approved generic drugs and non-prescription health products across various retail channels. Their operational footprint allows them to maintain a competitive edge in the global healthcare market, ensuring consistent product availability for consumers seeking affordable, effective health-care options.

Listed on the NYSE under the ticker PRGO, the company competes with major industry entities like Novartis, Teva, and Bristol-Myers Squibb. Perrigo continues to drive innovation in the healthcare market through strategic investments and a steadfast commitment to consumer well-being. Meet Perrigo's team to learn about their leadership and organizational structure, and Explore financial highlights to review their annual revenue of $4.1B and overall fiscal performance. This financial stability supports their ongoing efforts to expand their reach in the pharmaceutical industry while maintaining aView more...